Navigation Links
NeoStem Announces Conversion of Convertible Preferred Stock by Principal Shareholder
Date:5/20/2010

eport on Form 10-q filed with the Securities and Exchange Commission on May 17, 2010, as well as other periodic filings made with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

    For further information, please contact:

    NeoStem, Inc.
     Robin Smith, CEO
     Phone: +1-212-584-4174
     Email: rsmith@neostem.com
     Web:   http://www.neostem.com

    CCG Investor Relations, Inc.
     Lei Huang, Account Manager
     Phone: +1-646-833-3417
     Email: lei.huang@ccgir.com
     Web:   http://www.ccgirasia.com

     Crocker Coulson, President
     Phone: +1-646-213-1915
     Email: crocker.coulson@ccgir.com


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeoStem Announces NY State License for Adult Stem Cell Collection
2. NeoStem to Present at Third Annual Stem Cell Summit in New York City
3. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
4. NeoStem Featured in WCBS-TV Health Watch Segment on Adult Stem Cells
5. NeoStem to Expand Stem Cell Collection Center Network to Florida
6. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
7. Suzanne Somers To Promote Growing Importance of Storing Your Own Adult Stem Cells Under Alliance With NeoStem, Inc.
8. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
9. NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
10. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
11. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... VILLAGE, Nev. , July 28, 2015  PDL ... ) today announced that the Company will release its ... June 30, 2015, on Wednesday, August 5, 2015, after ... and webcast that day at 4:30 p.m. Eastern Time ... to the call will be available via the webcast ...
(Date:7/28/2015)... July 21, 2015 ... the addition of the "Analysis of the ... their offering. Globally, flow cytometry remains ... cell proliferation, cancer, and stem cells. But the ... primarily because of demand from underdeveloped nations to ...
(Date:7/28/2015)... , July 28, 2015 Tauriga Sciences, ... diversified life sciences company, today announced that its stockholders ... of common stock of the Company from 1,000,000,000 to ... July 27, 2015 at the Law Offices of Nixon ... the Special Meeting, there were 480,655,929 shares of common ...
(Date:7/28/2015)... KING OF PRUSSIA, Pa. , July 28, 2015 ... the U.S. Food and Drug Administration has accepted for ... novel investigational recombinant factor VIII single-chain (rVIII-SingleChain) for the ... rVIII-SingleChain met all primary endpoints. ... by deficient or defective factor VIII; nearly all affected ...
Breaking Biology Technology:PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
... Ltd. (Amex: CPD ) posted net sales for ... of $108.3 million, as compared to $35.4,million for the ... 206% over the first quarter of Fiscal 2008. Pre-tax ... Fiscal 2009 as compared to a,pre-tax income of $9.6 ...
... Company,s IPLEX(TM) Program in Myotonic ... Muscular Dystrophy, ... of follow-on biologics and biopharmaceuticals, today,announced that Geoffrey Allan, Ph.D., CEO ... of Innovative Therapeutics on,Thursday, August 7th, 2008 at 9:25 AM ET., ...
... 15.7%, ORANGE COUNTY, Calif., July 25 ... developer, manufacturer and marketer,of products that simplify, automate ... and first half ended June 30, 2008,results. Total ... 2007. In constant currency, revenue was up 11.2%. ...
Cached Biology Technology:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Insmed CEO to Present at Drug Discovery & Development Conference 2Beckman Coulter Announces Second Quarter 2008 Results 2Beckman Coulter Announces Second Quarter 2008 Results 3Beckman Coulter Announces Second Quarter 2008 Results 4Beckman Coulter Announces Second Quarter 2008 Results 5Beckman Coulter Announces Second Quarter 2008 Results 6Beckman Coulter Announces Second Quarter 2008 Results 7Beckman Coulter Announces Second Quarter 2008 Results 8Beckman Coulter Announces Second Quarter 2008 Results 9Beckman Coulter Announces Second Quarter 2008 Results 10Beckman Coulter Announces Second Quarter 2008 Results 11Beckman Coulter Announces Second Quarter 2008 Results 12Beckman Coulter Announces Second Quarter 2008 Results 13Beckman Coulter Announces Second Quarter 2008 Results 14Beckman Coulter Announces Second Quarter 2008 Results 15Beckman Coulter Announces Second Quarter 2008 Results 16Beckman Coulter Announces Second Quarter 2008 Results 17Beckman Coulter Announces Second Quarter 2008 Results 18Beckman Coulter Announces Second Quarter 2008 Results 19Beckman Coulter Announces Second Quarter 2008 Results 20Beckman Coulter Announces Second Quarter 2008 Results 21Beckman Coulter Announces Second Quarter 2008 Results 22Beckman Coulter Announces Second Quarter 2008 Results 23Beckman Coulter Announces Second Quarter 2008 Results 24Beckman Coulter Announces Second Quarter 2008 Results 25Beckman Coulter Announces Second Quarter 2008 Results 26Beckman Coulter Announces Second Quarter 2008 Results 27Beckman Coulter Announces Second Quarter 2008 Results 28
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/7/2015)... Calif. , July 7, 2015  Based ... market, Frost & Sullivan recognizes Credence ID, LLC ... Entrepreneurial Company of the Year Award. Credence ... to aid in its mission of offering enrollment ... populations globally. As Credence ID was formed by ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) ... Biometrics Market by Application, Technology, Function & Geography - ... The next generation biometrics market is expected ... of 17.9% between 2015 and 2020 Travel ... Safran SA ( France ), ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... an underwater area with little or no oxygen known commonly ... average, according to a forecast by a team of NOAA-supported ... and the University of Michigan. Scientists are predicting ... or an area roughly the size of the state of ...
... ITHACA, N.Y. Making better solar cells: Cornell ... molecules typically used in blue jean and ink dyes ... to economical, flexible and versatile solar cells. The discovery ... Today,s heavy silicon panels are effective, but they ...
... Institute of Physics (IOP) today, Tuesday 29 June 2010, ... Medal, IOP,s international medal, going to theoretical physicist Professor ... As one of the most influential physicists of the ... ranging from the phenomenology of particle physics and cosmology ...
Cached Biology News:NOAA-supported scientists predict 'larger than average' Gulf dead zone 2Molecules typically found in blue jean and ink dyes may lead to more efficient solar cells 2IOP announces 2010 award winners 2
... vinyl curtains or parting strip ... support frame to form a ... meets cleanliness to Class 10/ISO ... units, lights, and ionizers are ...
... The first high-density serum biomarker chip to ... proteins. An antibody chip containing 120 human ... that enables biomarker discovery scientists to study ... benefits of therapy and the likelihood of ...
... a highly sensitive reagent for the detection ... purified form of recombinant E. coli phosphate-binding ... is sensitive to changes in its environment.How ... Sensor is rapid and tight (Kd ~ ...
... modular benchtop fume hood ventilates ... safe indoor release of exhaust. ... organic contaminants. Configurations are available ... options include final HEPA filter, ...
Biology Products: